8 employees
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
2014
$36M
from 2 investors over 2 rounds
Aer Therapeutics, Inc. raised $36M on April 13, 2023
Investors: OrbiMed Advisors and Canaan